BLCO · Company research

Bausch + Lomb Corporation (BLCO): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

19records availableHealthcare

Stock News & Events data

Database-backed records only

19 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Bausch + Lomb Corporation (BLCO) Stock Forecasts - Yahoo FinanceBausch + Lomb Corporation (BLCO) Stock Forecasts Yahoo FinanceView source ↗Yahoo FinanceOct 12, 2026neutral00.6
Why Is Bausch + Lomb Stock Falling Monday? - Bausch Health Companies (NYSE:BHC), Bausch & Lomb (NYSE:BLCO - BenzingaWhy Is Bausch + Lomb Stock Falling Monday? - Bausch Health Companies (NYSE:BHC), Bausch & Lomb (NYSE:BLCO BenzingaView source ↗BenzingaOct 12, 2026neutral00.6
Bausch + Lomb Corporation (BLCO) Stock Price, News, Quote & History - Yahoo! Finance CanadaBausch + Lomb Corporation (BLCO) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 12, 2026neutral00.6
$BLCO stock is down 8% today. Here's what we see in our data. - Quiver Quantitative$BLCO stock is down 8% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeOct 12, 2026neutral00.6
Trading Systems Reacting to (BLCO) Volatility - Stock Traders DailyTrading Systems Reacting to (BLCO) Volatility Stock Traders DailyView source ↗Stock Traders DailyOct 10, 2026neutral00.6
How Investors Are Reacting To Bausch + Lomb (BLCO) FDA Backs Dry AMD Study - Simply Wall StreetHow Investors Are Reacting To Bausch + Lomb (BLCO) FDA Backs Dry AMD Study Simply Wall StreetView source ↗Simply Wall StreetOct 9, 2026neutral00.6
Bausch + Lomb (BLCO) Clarifies Dry AMD Trial Path, Is The Stock Still Undervalued? - Simply Wall StreetBausch + Lomb (BLCO) Clarifies Dry AMD Trial Path, Is The Stock Still Undervalued? Simply Wall StreetView source ↗Simply Wall StreetOct 8, 2026neutral00.6
A possible medicine to take by mouth for macular degeneration is planned for 2027 testing - Stock TitanA possible medicine to take by mouth for macular degeneration is planned for 2027 testing Stock TitanView source ↗Stock TitanOct 6, 2026neutral00.6
Bausch + Lomb will give a business update in a live webcast at 8 a.m. Oct. 28 - Stock TitanBausch + Lomb will give a business update in a live webcast at 8 a.m. Oct. 28 Stock TitanView source ↗Stock TitanOct 5, 2026neutral00.6
Bausch + Lomb (BLCO) Earnings Date and Reports 2026 - MarketBeatBausch + Lomb (BLCO) Earnings Date and Reports 2026 MarketBeatView source ↗MarketBeatOct 2, 2026neutral00.6
Bausch + Lomb (BLCO) Stock Trades Below Fair Value As Caution Lingers - Yahoo FinanceBausch + Lomb (BLCO) Stock Trades Below Fair Value As Caution Lingers Yahoo FinanceView source ↗Yahoo FinanceAug 29, 2026neutral00.6
3 Healthcare Stocks We Steer Clear Of - StockStory3 Healthcare Stocks We Steer Clear Of StockStoryView source ↗StockStoryAug 26, 2026neutral00.6
What's Going On With Bausch + Lomb Stock Tuesday? - Bausch & Lomb (NYSE:BLCO) - BenzingaWhat's Going On With Bausch + Lomb Stock Tuesday? - Bausch & Lomb (NYSE:BLCO) BenzingaView source ↗BenzingaAug 25, 2026neutral00.6
Bausch + Lomb eye drop cut pain duration from 37.8 seconds to 1.6 - Stock TitanBausch + Lomb eye drop cut pain duration from 37.8 seconds to 1.6 Stock TitanView source ↗Stock TitanAug 24, 2026neutral00.6
Bausch + Lomb (BLCO) Lifts 2026 Revenue Guidance, Is The Stock Still 57% Undervalued? - Yahoo FinanceBausch + Lomb (BLCO) Lifts 2026 Revenue Guidance, Is The Stock Still 57% Undervalued? Yahoo FinanceView source ↗Yahoo FinanceJul 31, 2026neutral00.6
Bausch + Lomb (BLCO) Stock Rallies On Margin Gains As Losses Narrow - Simply Wall StreetBausch + Lomb (BLCO) Stock Rallies On Margin Gains As Losses Narrow Simply Wall StreetView source ↗Simply Wall StreetJul 30, 2026neutral00.6
Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today - StockStoryWhy Bausch + Lomb (BLCO) Stock Is Trading Lower Today StockStoryView source ↗StockStoryJul 10, 2026neutral00.6
BLCO Stock Drops After-Hours — Bausch + Lomb Halts Glaucoma Eye Drop Program After Trial Failure - StocktwitsBLCO Stock Drops After-Hours — Bausch + Lomb Halts Glaucoma Eye Drop Program After Trial Failure StocktwitsView source ↗StocktwitsJul 9, 2026neutral00.6
BLCO Stock Price and Chart — NYSE:BLCO - TradingViewBLCO Stock Price and Chart — NYSE:BLCO TradingViewView source ↗TradingViewFeb 18, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.